Viasit M 50/500mg (14 Tablet / Pack)

A dual-action oral combination antidiabetic tablet for the customized, step-up management of Type 2 Diabetes Mellitus.

PKR 434.00

You save: PKR 0

Quantity:

SKU: VIASIT_M_50500MG_14_TABLET_PACK

Category: Tablets & Capsules

Viasit M 50/500mg (14 Tablet / Pack) is a balanced, lower maintenance strength oral antihyperglycemic fixed-dose combination combining Sitagliptin Phosphate with a reduced dose of Metformin Hydrochloride. Designed to optimize blood sugar profiles in Type 2 Diabetes patients requiring structured incretin enhancement with mild biguanide support, it effectively lowers HbA1c values while maintaining a highly favorable gastrointestinal tolerability threshold.

Purpose

Blends a DPP-4 inhibitor with a low-dose biguanide to safely manage blood glucose levels and minimize gastrointestinal side effects.

Ingredients

Sitagliptin (as Phosphate) 50mg, Metformin Hydrochloride 500mg

Warnings

Utilize strictly as an auxiliary adjunct to a structured, clinician-approved dietary plan and routine physical exercise program. Monitor the patient closely for severe, unyielding abdominal pain that radiates to the back, which could indicate acute pancreatitis. Check blood glucose metrics routinely; baseline doses of co-prescribed insulin or sulfonylureas may need adjusting to avoid hypoglycemia. Regularly evaluate baseline and ongoing renal clearance profiles to ensure the safe systemic elimination of both active drugs.

Side Effects

Mild, transient gastrointestinal changes such as low-grade nausea, temporary flatulence, or soft stools post-ingestion. Low-grade nasopharyngitis, minor nasal congestion, or a brief upper respiratory throat tickle. Minor, transient headache, brief morning lightheadedness, or slight physical tiredness. Potential for localized hypersensitivity reactions including low-grade pruritus or minor skin rashes.